Kronos Early Estrogen Prevention Study (KEEPS)

Trial Profile

Kronos Early Estrogen Prevention Study (KEEPS)

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2017

At a glance

  • Drugs Conjugated estrogens (Primary) ; Estradiol (Primary) ; Progesterone
  • Indications Atherosclerosis; Menopausal syndrome
  • Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
  • Acronyms KEEPS; KEEPS-CA
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Oct 2012 KEEPS-CA substudy results presented at the 23rd Annual Meeting of the North American Menopause Society.
    • 06 Oct 2012 Results assessing the effects of treatment on platelet-associated and plasma protein levels presented at the 23rd Annual Meeting of the North American Menopause Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top